Summary
The influence of bovine lactoferrin (bLf) on colon carcinogenesis was investigated in male F344 rats treated with azoxymethane (AOM). In experiment I, 2% and 0.2% bLf, and Bifidobacterium longum (B. longum) as a positive control at 3% were given in the diet for 4 weeks, along with two s.c. 15 mg/kg injections of AOM on days 1 and 8. The numbers of aberrant crypt foci (ACF) were decreased by both treatments. Similar results were obtained in experiment II of 13 weeks duration. In experiment III, animals were given three weekly injections of AOM and then received 2 or 0.2% bLf, 2% bLf-hydrolysate, or 0.1% bovine lactoferricin (bLfcin) for 36 weeks. No effects indicative of toxicity were noted, but significant reduction in both the incidence and number of adenocarcinomas of the large intestine was observed with almost all the treatments. Thus, the incidences of colon adenocarcinomas in the groups receiving 2 or 0.2% bLf, 2% bLf-hydrolysate, or 0.1% bLfcin were 15%, 25%, 26.3% and only 10%, respectively, in contrast to the 57.5% control value (p < 0.01). ACF values also exhibited reduced development. Investigation of beta-glucuronidase revealed decrease in the cecal contents of animals receiving bLf. In addition, demonstration of enhancement of NK activity by bLf indicated that its inhibitory effects could have been related to elevated immune cytotoxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Giovannucci, E. and Willett, W. C. Dietary factors and risk of colon cancer. Ann. Med., 26: 443–452, 1994.
Wynder, E. L., Fujita, Y., Harris, R. E., Hirayama, T. and Hiyama, T. Comparative epidemiology of cancer between the United States and Japan, a second look. Cancer, 67: 746–63, 1991.
Wattenberg, L. W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. (suppl.), 52: 2085s - 2091s, 1992.
McIntosh, G. H., Regester, G. O., Lc, L. R., Royle, P. J. and Smithers, G. W. Dairy proteins protect against dimethylhydrazinc-induced intestinal cancers in rats. J. Nutr., 125: 809–816, 1995.
Lonncrdal, B. and lyer. S. Lactoferrin: molecular structure and biological function review. Ann. Rev. Nutr., 15: 93–110, 1995.
Nishiya, K. and Horwitz, D. A. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J. Immunol., 129: 2519–2523, 1982.
Shan, H., Kim. A. and Golub, S. H. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukocyte Biol., 51: 343–349, 1992.
Gahr, M., Speer, C. P., Damerau, B. and Sawatzki, G. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J. Leukocyte Biol., 49: 427–433. 1991.
Sawatzki_ G. and Rich, I. N. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells, 15: 371–385, 1989.
McCormick, J. A., Markey, G. M. and Morris, T. C. Lactoferrin-inducible monocyte cytotoxicity for K562 cells and decay of natural killer lymphocyte cytotoxicity. Clin. Exp. Immunol., 83: 154–156, 1991.
Levay, P. F. and Viljoen, M. Lactoferrin: a general review. Haematologica, 80: 252–267, 1995.
Bezault, J., l3himani. R., Wiprovnick, J. and Furmanski, P. Human lactoferrin inhibits growth of solid tu-mors and development of experimental metastases in mice. Cancer Res., 54: 231–2312, 1994.
Reddy, B. S., Simi, B., Patel. N., Aliaga, C. and Rao, C. V. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion. Cancer Res., 56: 2314–2320, 1996.
Reddy, B. S. and Rivenson, A. Inhibitory effect of Bi/ìdohacteriurn longuet on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-fjquinoline, a food mutagen. Cancer Res., 53: 3914–3918, 1993.
Abdelali, F1., Cassand, P., Soussotte, V., Daubeze, M., Bouley, C. and Narbonne, J. F. Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr. Cancer, 24: 121–132, 1995.
Kulkarni, N. and Reddy, B. S. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethaneinduced aberrant crypt foci formation and fecal bacterial beta-glucuronidase. Proc. Soc. Exp. Biot. Med., 207: 278–283, 1994.
Tornita, M., Bellamy, W., Takasc, M., Yamauchi, K., Wakabayashi, H. and Kawase, K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci., 74: 4137–4142, 1991.
Bellamy, W.. Takase, M., Wakabayashi, FI., Kawase. K. and Tornita, M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Applied Bacteriol., 73: 472 479. 1992.
Shimamura. S.., Abe. F., Ishibashi, N., Miyakawa, H., Yaeshima, T., Araya, T. and Tornita, M. Relationship between oxygen sensitivity and oxygen metabolism of Bifidobacterium species. J. Dairy Sei., 75: 3296 3306, 1992.
Winter, 13. K., Wu, S., Nelson, A. C. and Pollack. S. B. Renal cell carcinoma and natural killer cells: studies in a novel rat model in vitro and in vivo. Cancer Res., 52: 6279–6286, 1992.
Sekine, K., Ohta, J., Onishi, M., Tatsuki, T., Shimokawa, Y., Toida, T., Kawashima, T. and Hashimoto, Y. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifido-bacterium inl4ntis. Biol. Pharm. Bull., 18: 148–153, 1995.
Rowland, I. R., Mallett, A. K. and Wise, A. A comparison of the activity of five microbial enzymes in cecal content fì-om rats, mice, and hamsters, and response to dietary pectin. Toxicol. Appt. Pharm., 69: 143–148, 1983.
Tudek, 13., Bird, R. P. and Bruce, W. R. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res., 49: 1236–1240, 1989.
Bird. R. P., Yao, K., Lasko, C. M. and Good. C. K. Inability of low-or high-fat diet to modulate late stages of colon carcinogenesis in Sprague-Dawley rats. Cancer Res., 56: 2896–2899, 1996.
Kampman, E.. Goldbohm, R. A., Van den Brandt, P. A. and Van’t Veer, P. Fermented dairy products, calcium, and colorectal cancer in the Netherlands cohort study. Cancer Rcs., 54: 3186–3190, 1994.
Sorenson, A. W., Slattery, M. L. and Ford, M. H. Calcium and colon cancer: a review. Nutr. Cancer, 2: 135–145, 1988.
Tsuru, S., Shinomiya, N., Taniguchi, M., Shimazaki, H., Tanigawa, K. and Nomoto, K. Inhibition of tumor growth by dairy products. J. Clin. Lab. Immunol., 25: 177–183, 1988.
Bounous, G.. Papenburg, R., Kongshavn, P. A., Gold, P. and Fleiszer, D. Dietary whey protein inhibits the development of dimethylhydrazine induced malignancy. Clin. Invest. Med., 2: 213 217, 1988.
Papenburg, R., Bounous, G., Fleiszer, D. and Gold, P. Dietary milk proteins inhibit the development of dimethylhydrazine-induced malignancy. Tumour Biol., 11: 129–136, 1990.
Kennedy, R. S., Konok, G. P., Bounous, G., Baruchel, S. and Lee, T. D. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase 1–11 clinical study. Anticancer Res., 15: 2643–2649, 1995.
Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93: 55–71, 1995.
Brock, J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol. Today, 16: 417–419, 1995.
Sekine, K., Kawashima, T. and Hashimoto, Y. Comparison of the TNF-a levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobacteria Microflora, 13: 79–89, 1994.
Wei, W. Z., Fulton, A., Winkelhake, J. and Heppner, G. Correlation of natural killer activity with tumorigenesis of a preneoplastic mouse mammary lesion. Cancer Res., 49: 2709–2715, 1989.
Bounous, G., Batist, G. and Gold, P. Whey protein in cancer prevention. Cancer Lett., 57: 91–94, 1991.
Goldin, B. R. and Gorbach, S. L. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. A. J. Clin. Nutr., 39: 756–761, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tsuda, H. et al. (1998). Inhibition of Azoxymethane Initiated Colon Tumor and Aberrant Crypt Foci Development by Bovine Lactoferrin Administration in F344 Rats. In: Spik, G., Legrand, D., Mazurier, J., Pierce, A., Perraudin, JP. (eds) Advances in Lactoferrin Research. Advances in Experimental Medicine and Biology, vol 443. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9068-9_34
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9068-9_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9070-2
Online ISBN: 978-1-4757-9068-9
eBook Packages: Springer Book Archive